Understand the source comparison
How to Heal Faster After Surgery with Peptides: Protocol Comparison
BPC-157 Reduces pro-inflammatory cytokines (IL-6, TNF-alpha); stabilizes nitric oxide synthase activity Inflammatory (days 0–5) 250–500mcg twice daily Subcutaneous (near wound if feasible) Gold standard for early post-op inflammation control. Start within 24–4
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Reduces pro-inflammatory cytokines (IL-6, TNF-alpha); stabilizes nitric oxide synthase activity
- Inflammatory (days 0–5)
- 250–500mcg twice daily
- Subcutaneous (near wound if feasible)
- Gold standard for early post-op inflammation control. Start within 24–48 hours for maximum effect
- TB-500 (Thymosin Beta-4)
- Upregulates actin polymerization; accelerates fibroblast migration and angiogenesis
- Proliferative (days 4–21)
- 2–2.5mg twice weekly
- Subcutaneous (systemic)
- Most studied peptide for tissue repair. Timing matters more than dose; delayed start reduces efficacy significantly
- GHK-Cu (Copper Peptide)
- Activates matrix metalloproteinases; stimulates VEGF for blood vessel formation; improves collagen architecture
- Proliferative to Remodeling (days 4–56)
- 1–2mg daily
- Subcutaneous or topical (if wound closed)
- Exceptional for scar quality. Underutilized in surgical recovery despite strong clinical evidence
- KPV
- Anti-inflammatory tripeptide; modulates NF-kB pathway to reduce cytokine storm
- 500mcg–1mg twice daily
- Subcutaneous
- Newer compound with limited human trial data but promising preclinical results in wound inflammation models
- MK-677 (Ibutamoren)
- Growth hormone secretagogue; elevates IGF-1 systemically
- Systemic support (entire recovery period)
- 12.5–25mg once daily (oral)
- Oral capsule
- Indirect healing support through elevated IGF-1. Not wound-specific but valuable for muscle preservation and metabolic recovery